Page last updated: 2024-08-21

lithocholic acid and Breast Neoplasms

lithocholic acid has been researched along with Breast Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Arya, GC; Jaitak, V; Kaur, K1
Hasirci, N; Isik, G; Kiziltay, A; Tezcaner, A1
Arshad, R; Batool, A; Kiani, MH; Nousheen, K; Razzaq, S; Shahnaz, G1
Bard, JM; Bobin-Dubigeon, C; Carbonnelle, D; Chaillou, C; Huvelin, JM; Luu, TH; Nazih, H1
Antal-Szalmás, P; Bai, P; Boratkó, A; Csoka, B; Csonka, T; Goedert, JJ; Gombos, I; Hujber, Z; Kiss, B; Kovács, P; Kovács, T; Márton, J; Méhes, G; Mikó, E; Sári, Z; Sebestyén, A; Szabó, J; Trencsényi, G; Ujlaki, G; Vida, A; Vígh, L; Watanabe, M1
Beach, A; Davies, GF; Goldberg, AA; Harkness, TA; Leblanc, A; Titorenko, VI1

Reviews

1 review(s) available for lithocholic acid and Breast Neoplasms

ArticleYear
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
    European journal of medicinal chemistry, 2021, Oct-05, Volume: 221

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles

2021

Other Studies

5 other study(ies) available for lithocholic acid and Breast Neoplasms

ArticleYear
Lithocholic acid conjugated mPEG-b-PCL micelles for pH responsive delivery to breast cancer cells.
    International journal of pharmaceutics, 2022, Jun-10, Volume: 621

    Topics: Breast Neoplasms; Drug Carriers; Female; Humans; Hydrogen-Ion Concentration; Lithocholic Acid; Micelles; Polyesters; Polyethylene Glycols

2022
Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    International journal of biological macromolecules, 2020, Jun-01, Volume: 152

    Topics: Administration, Oral; Breast Neoplasms; Cystamine; Disulfides; Drug Carriers; Drug Delivery Systems; Drug Design; Drug Liberation; Drug Screening Assays, Antitumor; Emulsions; Female; Hemolysis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Inhibitory Concentration 50; Lithocholic Acid; MCF-7 Cells; Nanomedicine; Nanoparticles; Particle Size; Permeability; Polymers; Solubility; Surface-Active Agents; Tamoxifen

2020
Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.
    Cellular oncology (Dordrecht), 2018, Volume: 41, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estrogen Receptor alpha; Gene Expression; Humans; Lipid Droplets; Lipogenesis; Lithocholic Acid; MCF-7 Cells; Receptors, G-Protein-Coupled

2018
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.
    Biochimica et biophysica acta. Bioenergetics, 2018, Volume: 1859, Issue:9

    Topics: Animals; Apoptosis; Bacteria; Breast Neoplasms; Cell Movement; Cell Proliferation; Detergents; Female; Humans; Lithocholic Acid; Mice; Mice, Inbred BALB C; Middle Aged; Prognosis; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.
    Oncotarget, 2011, Volume: 2, Issue:10

    Topics: Animals; Brain Neoplasms; Breast Neoplasms; Caspase 3; Caspase 6; Cells, Cultured; Detergents; Female; Glioma; Histones; Humans; Hydrogen Peroxide; Immunoblotting; Lithocholic Acid; Membrane Potential, Mitochondrial; Mitochondria; Neuroblastoma; Neurons; Phosphorylation; Rats

2011